Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Acalabrutinib 100 / Obinutuzumab (100/900/1000), Chronic Lymphocytic Leukemia, Cycle 2

Protocol-ID: 1655 V1.2 (Mini), ACAL100/OBIN(100/900/1000), CLL, C2

Indication(s)

  • Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma; ICD-10 C91.1-
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 10.04.2024